Home/ Crypto News/ Tyra Biosciences (TYRA) Shares Plunge 22% as Bladder Cancer Drug Trial Falls Short

blockonomi 1 week ago

Tyra Biosciences (TYRA) Shares Plunge 22% as Bladder Cancer Drug Trial Falls Short

Stocks

Tyra Biosciences (TYRA) stock plunged 22% after its bladder cancer drug dabogratinib achieved a 64% response rate, missing the 70% analyst benchmark.

The post Tyra Biosciences (TYRA) Shares Plunge 22% as Bladder Cancer Drug Trial Falls Short appeared first on Blockonomi.

Source: Source: Blockonomi